AGER and acute respiratory distress syndrome: The receptor for advanced glycation end-products (RAGE) and its soluble form, sRAGE, are primarily expressed by type I pneumocytes (9, 10); they have been well-characterized as markers of pulmonary type I alveolar epithelial cell injury and as diagnostic and prognostic biomarkers in ARDS (11, 12).